Guardant Health Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Thanks so much. You've got Liza Garcia here, UBS Life Science Tools and Diagnostics with John Sourbeer, and we are very, very fortunate. We have here AmirAli from Guardant, Co-CEO. He will be joining us for a panel on liquid biopsy and all the exciting things that Guardant is doing at the moment. And so thank you very much, and welcome.
Thanks for having me.
Well, let's start off, I guess, is kind of something top of mind, reimbursement win for Reveal at the beginning of the month. Obviously, yours has a little bit different than maybe some of the other colorectal MRD tests in the market. So I was hoping you could kind of update us on the reimbursement amount that you have with Medicare. For Reveal as the only blood-only offering and kind of where it stands,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
